← FDA Drug Approvals (Drugs@FDA)

VIMPAT

NDA · New Drug Application · Sponsor: UCB INC · Approved 2008-10-28

Drug application

FDA Application #

NDA022254

Application type

New Drug Application

Brand name

VIMPAT

Generic name

LACOSAMIDE

Active ingredients

LACOSAMIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

UCB INC

Manufacturer

UCB, Inc.

First approval

2008-10-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown